comparemela.com

Latest Breaking News On - Japan takeda pharmaceutical co - Page 1 : comparemela.com

Wipro lost its CFO to Cognizant Then it lost a big client

Why now is the time for Canadians to diversify their portfolios with international stocks

Novartis Sells Eye Drugs to Bausch for Up to $2 5B

The deal includes Xiidra, a prescription medicine for dry eye disease, that generated $487 million in sales last year.

AI-made drug starts human trials

We've curated insightful analysis on how generative AI is being used to make drugs more efficiently than traditional methods.

Takeda: HYQVIA Gets FDA Approval To Treat Primary Immunodeficiency In Children

Japan's Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Tuesday that the U.S. Food and Drug Administration has approved a supplemental biologics license application or sBLA to expand the use of HYQVIA to treat primary immunodeficiency or PI in children 2-16 years old.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.